Stephanie Snow+FollowNovavax Gets the Green Light—But With a CatchNovavax’s COVID-19 vaccine just scored full FDA approval, but here’s the twist: it’s only for people 65+ or those 12–64 with health risks. Unlike Pfizer and Moderna, this protein-based shot isn’t for everyone yet—kids under 12 are still waiting on more data. The FDA’s also asking for more studies, especially on heart safety. If you’ve been holding out for a non-mRNA option, this could be your moment (if you qualify)! #Novavax #COVID19Vaccine #FDAApproval #HealthNews #VaccineUpdate #Health10Share
elizabethwang+FollowNovavax Vax Gets Green Light—With a CatchThe FDA just approved Novavax’s COVID vaccine, but there’s a twist: it’s only for people 65+ or anyone 12-64 with a health condition that ups their COVID risk. No word yet on what counts as an ‘underlying condition’—classic FDA move. If you were hoping for a new vax option for kids, you’ll have to wait; those studies aren’t done yet. Big milestone for Novavax, but definitely not a free-for-all! #Novavax #COVID19 #FDAApproval #VaccineUpdate #Health20Share
Chris Lyons+FollowFDA Says Hold Off on This Travel VaccineIf you’re over 60 and planning a trip, heads up: the FDA just warned seniors to skip the new chikungunya vaccine (Ixchiq) for now. After a couple of serious (even deadly) complications in older adults, they’re hitting pause until they know more. The vaccine’s supposed to protect against a nasty mosquito virus, but right now, the risks might outweigh the benefits for seniors. If you or your parents are traveling soon, double-check before getting this shot! #FDAWarning #TravelHealth #VaccineUpdate #SeniorSafety #Chikungunya #Health20Share
reyesbrian+FollowFDA Pauses Chikungunya Vax for 60+Big update on the new chikungunya vaccine: If you or someone you know is 60+, the FDA and CDC are telling folks to hit pause on getting the Ixchiq shot for now. This comes after two reported deaths and some serious side effects in older adults. They’re digging into the data to see what’s up, but for now, better safe than sorry! If you’re traveling somewhere with chikungunya, definitely check with your doc before making any moves. #HealthNews #VaccineUpdate #Chikungunya #FDA #CDC #Health00Share
Spencer Brewer+FollowRSV Vaccine: 75% Effective for 60+ Crowd!Big news for anyone with older parents or at-risk friends: the RSV vaccine is showing 75% effectiveness at keeping folks 60+ out of the ER and hospital! Even immunocompromised people saw strong protection, though it dipped for some. There’s a tiny uptick in Guillain-Barré syndrome risk, especially with one version, but overall safety looks solid. The CDC’s now recommending the shot for high-risk adults as young as 50. Would you get it for your family? #RSVvaccine #HealthNews #OlderAdults #VaccineUpdate #PublicHealth #Health01Share
nathan87+FollowChikungunya Vax Paused for Seniors—Here’s WhyThe FDA and CDC just hit pause on the chikungunya vaccine IXCHIQ for people 65+ after some serious side effects popped up—one even fatal. No official link to the vaccine yet, but they’re playing it safe for now. If you’re under 65, you’re still good to get it, especially if you’re traveling to outbreak zones. Over 40,000 doses have already been given worldwide, and the investigation’s ongoing. Stay tuned for updates! #Chikungunya #VaccineUpdate #HealthNews #FDA #CDC #Health00Share
Courtney Williams+FollowBird Flu Drama: Labs, Mutations & Missed ShotsDid you know scientists are racing to outsmart a super-mutating bird flu? Labs are testing everything from cows to bobcats, but funding cuts are making it harder to keep up. The virus is evolving fast, and experts say we might need a new mRNA vaccine ASAP. Meanwhile, a third of people say they wouldn’t even take it! With the virus jumping from birds to mammals, this could be the next big thing—if we’re not careful. #BirdFlu #ScienceNews #VaccineUpdate #PublicHealth #LabLife #Health10Share
Michelle Chen+FollowChikungunya Vaccine Drama in EuropeEurope just hit pause on Valneva’s new chikungunya vaccine for folks 65+ after some serious side effects popped up—including two deaths. The vaccine, which was supposed to protect against the mosquito-borne virus, is now under review. The company’s working with health authorities to figure out what’s going on, but for now, older adults are being told to skip it. Wild how fast things can change with new meds! #healthnews #vaccineupdate #chikungunya #Europe #Valneva #Health00Share
xwest+FollowNo New COVID Boosters This Winter?Just heard the FDA might skip updating COVID boosters for next season! They want vaccine makers to prove the shots really work with solid clinical trials, not just antibody spikes. This could mean no new booster for most of us this winter—maybe just for high-risk folks. Honestly, with so few people getting the last booster, are you surprised? Let’s see what happens next! #COVID19 #VaccineUpdate #FDA #HealthNews #WatercoolerMoment #Health3855Share
Spencer Brewer+FollowFDA Might Shake Up COVID Booster RulesBig news: The FDA is rethinking how it approves COVID boosters for this winter. Usually, they just update the shot like they do with flu vaccines, but now they want fresh data to prove the new boosters actually work. Fewer people got boosted last year (even healthcare workers!), so confidence might be slipping. The CDC could also recommend boosters just for high-risk folks instead of everyone. What do you think—should boosters be for all, or just some? #COVID19 #FDA #VaccineUpdate #HealthNews #PublicHealth #Health2714Share
